Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1978 Mar;13(3):473–478. doi: 10.1128/aac.13.3.473

Interactions between Neisseria sicca and viridin B, a bacteriocin produced by Streptococcus mitis.

D J Law, A S Dajani
PMCID: PMC352266  PMID: 263887

Abstract

Viridin B, a bacteriocin produced by Streptococcus mitis (mitior), is bactericidal to Neisseria sicca. Oxygen consumption by actively growing N. sicca cultures ceased immediately upon exposure to viridin B. Adenosine triphosphate production was slightly enhanced within 1 h of exposure to the bacteriocin but was subsequently repressed. The uptake and incorporation of glucose was prevented in the presence of viridin B. The bacteriocin also blocked uptake of an amino acid mixture in chloramphenicol-pretreated cells. Pretreatment or concomitant treatment with a variety of antibiotics known to inhibit specific synthetic pathways did not alter the inhibition of macromolecular synthesis produced by the bacteriocin. Although viridin B blocks protein and nucleic acid syntheses, no degradation of such macromolecules was observed. The inhibitory effects of viridin B on macromolecular synthesis and on viability required the presence of sufficient nutrients to allow active metabolism of N. sicca. The bacteriocin did not inhibit viability or macromolecular synthesis in anaerobically incubated N. sicca. Thus, active, oxidative metabolism by N. sicca cells is essential for viridin B action. A model for viridin B action is proposed.

Full text

PDF
475

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Basinger S. F., Jackson R. W. Bacteriocin (hemolysin) of Streptococcus zymogenes. J Bacteriol. 1968 Dec;96(6):1895–1902. doi: 10.1128/jb.96.6.1895-1902.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Boon T. Inactivation of ribosomes in vitro by colicin E 3 and its mechanism of action. Proc Natl Acad Sci U S A. 1972 Mar;69(3):549–552. doi: 10.1073/pnas.69.3.549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dajani A. S., Law D. J., Bollinger R. O., Ecklund P. S. Ultrastructural and biochemical alterations effected by viridin B, a bacterocin of alpha-hemolytic streptococci. Infect Immun. 1976 Sep;14(3):776–782. doi: 10.1128/iai.14.3.776-782.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dajani A. S., Tom M. C., Law D. J. Viridins, bacteriocins of alpha-hemolytic streptococci: isolation, characterization, and partial purification. Antimicrob Agents Chemother. 1976 Jan;9(1):81–88. doi: 10.1128/aac.9.1.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Greenawalt J. W., Whiteside T. L. Mesosomes: membranous bacterial organelles. Bacteriol Rev. 1975 Dec;39(4):405–463. doi: 10.1128/br.39.4.405-463.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. HOLLAND I. B. A BACTERIOCIN SPECIFICALLY AFFECTING DNA SYNTHESIS IN BACILLUS MEGATERIUM. J Mol Biol. 1965 Jun;12:429–438. doi: 10.1016/s0022-2836(65)80265-0. [DOI] [PubMed] [Google Scholar]
  7. Haddock B. A., Jones C. W. Bacterial respiration. Bacteriol Rev. 1977 Mar;41(1):47–99. doi: 10.1128/br.41.1.47-99.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Jetten A. M., Vogels G. D. Characteristics of the killing effect of a Staphylococcus epidermidis bacteriocin. Antonie Van Leeuwenhoek. 1974;40(1):177–183. doi: 10.1007/BF00394565. [DOI] [PubMed] [Google Scholar]
  9. Jetten A. M., Vogels G. D. Mode of action of a Staphylococcus epidermidis bacteriocin. Antimicrob Agents Chemother. 1972 Dec;2(6):456–463. doi: 10.1128/aac.2.6.456. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Mahony D. E., Butler M. E. Bacteriocins of Clostridium perfringens. 1. Isolation and preliminary studies. Can J Microbiol. 1971 Jan;17(1):1–6. doi: 10.1139/m71-001. [DOI] [PubMed] [Google Scholar]
  11. Stanley P. E., Williams S. G. Use of the liquid scintillation spectrometer for determining adenosine triphosphate by the luciferase enzyme. Anal Biochem. 1969 Jun;29(3):381–392. doi: 10.1016/0003-2697(69)90323-6. [DOI] [PubMed] [Google Scholar]
  12. Tagg J. R., Dajani A. S., Wannamaker L. W. Bacteriocins of gram-positive bacteria. Bacteriol Rev. 1976 Sep;40(3):722–756. doi: 10.1128/br.40.3.722-756.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Tagg J. R., Dajani A. S., Wannamaker L. W., Gray E. D. Group A streptococcal bacteriocin. Production, purification, and mode of action. J Exp Med. 1973 Nov 1;138(5):1168–1183. doi: 10.1084/jem.138.5.1168. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES